Jeff Conn
Vanderbilt Investigational Alzheimer's Drug Scheduled for First Study in Humans
Jan 10, 2017 at 11:16 am by Staff
In late December, Vanderbilt University scientists received the green light from the U.S. Food and Drug Administration (FDA) to proceed to clinical testing in humans for an in.... Read More